These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5810249)

  • 21. Anticoagulant and antithrombotic action of novel specific inhibitors of thrombin.
    Hauptmann J; Kaiser B; Markwardt F; Nowak G
    Thromb Haemost; 1980 Jun; 43(2):118-23. PubMed ID: 7455968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Synthetic inhibitors of serine proteinases. Part 25: Inhibition of trypsin, plasmin and thrombin by amides of N alpha-substituted amidinophenylalanines and 3-amidinophenyl-3-aminopropionic acids (author's transl)].
    Stürzebecher J; Horn H; Markwardt F; Wagner G; Walsmann P
    Pharmazie; 1981 Sep; 36(9):639-41. PubMed ID: 6458047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationship studies of neuronal monoamine uptake inhibition of pyridylallylamines.
    Singh P
    Indian J Biochem Biophys; 1984 Dec; 21(6):406-8. PubMed ID: 6545533
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of acrosin by benzamidines.
    Stürzebecher J
    Acta Biol Med Ger; 1981; 40(10-11):1519-22. PubMed ID: 7044006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Synthetic inhibitors of serine proteinases. 31. The inhibition of trypsin, plasmin and thrombin by isomeric compounds of N alpha -arylsulfonylated omega-amidinophenyl-alpha-aminoalkylcarboxylic acid amides].
    Stürzebecher J; Markwardt F; Vieweg H; Wagner G; Walsmann P
    Pharmazie; 1984 Jun; 39(6):411-3. PubMed ID: 6237371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Structure-activity relations with respect to guanylhydrazones of various substituted aliphatic, aromatic, and cyclic basic substances].
    Hamacher J; Adenauer F; Kalversiep G; Krüger E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):267-8. PubMed ID: 5804288
    [No Abstract]   [Full Text] [Related]  

  • 27. [Synthesis of N alpha-(tosyl-beta-alanyl)- and N alpha-(tosyl-epsilon-aminocapronyl)amidinophenylalanineamides as strongly effective inhibitors of thrombin].
    Wagner G; Voigt B; Pfeiffer C
    Pharmazie; 1984 May; 39(5):315-7. PubMed ID: 6473488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Irreversible enzyme inhibitors. CLII. Proteolytic enzymes. X. Inhibition of guinea pig complement by substituted benzamidines.
    Baker BR; Erickson EH
    J Med Chem; 1969 May; 12(3):408-14. PubMed ID: 5788155
    [No Abstract]   [Full Text] [Related]  

  • 29. Bis-cationic heteroaromatics as macrofilaricides: synthesis of bis-amidine and bis-guanylhydrazone derivatives of substituted imidazo[1,2-a]pyridines.
    Sundberg RJ; Biswas S; Kumar Murthi K; Rowe D; McCall JW; Dzimianski MT
    J Med Chem; 1998 Oct; 41(22):4317-28. PubMed ID: 9784107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacious and orally bioavailable thrombin inhibitors based on a 2,5-thienylamidine at the P1 position: discovery of N-carboxymethyl-d-diphenylalanyl-l-prolyl[(5-amidino-2-thienyl)methyl]amide.
    Lee K; Park CW; Jung WH; Park HD; Lee SH; Chung KH; Park SK; Kwon OH; Kang M; Park DH; Lee SK; Kim EE; Yoon SK; Kim A
    J Med Chem; 2003 Aug; 46(17):3612-22. PubMed ID: 12904065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Synthesis of N alpha-(arylsulfonylglycylglycyl)-4-amidinophenylalanine amides as thrombin inhibitors].
    Voigt B; Wagner G
    Pharmazie; 1984 Jun; 39(6):379-81. PubMed ID: 6483943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral agents 1978-1983.
    Swallow DL
    Prog Drug Res; 1984; 28():127-95. PubMed ID: 6435171
    [No Abstract]   [Full Text] [Related]  

  • 33. Centrally acting emetics. 3. Derivatives of beta-naphthylamine.
    Sprenger WK; Cannon JG; Barman BK; Burkman AM
    J Med Chem; 1969 May; 12(3):487-90. PubMed ID: 5788165
    [No Abstract]   [Full Text] [Related]  

  • 34. [Different N-substutuents of phthalamic acid. Effect on geotropism of germinating roots of Lens esculenta Moench, s.l].
    Pagani G; Baruffini A; Borgna P; Caccialanza G
    Farmaco Sci; 1968 May; 23(5):448-67. PubMed ID: 5680385
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis of benzamidine derivatives as inhibitors of clotting enzymes.
    Wagner G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):67-74. PubMed ID: 6177610
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthetic, low molecular thrombin inhibitors. A new concept of anticoagulants?
    Markwardt F
    Haemostasis; 1974; 3(4):185-202. PubMed ID: 4459213
    [No Abstract]   [Full Text] [Related]  

  • 37. A novel series of synthetic thrombin-inhibitors. II. Relationships between structure of modified OM-inhibitors and thrombin inhibitory effect.
    Tonomura S; Kikumoto R; Tamao Y; Ohkubo K; Okamoto S; Kinjo K; Hijikata A
    Kobe J Med Sci; 1980 Mar; 26(1):1-9. PubMed ID: 7190199
    [No Abstract]   [Full Text] [Related]  

  • 38. [UV-spectrophotometry in drug control. Effect of substitution and solvent on UV-spectrophotometric behavior of drugs with benzol-chromophore].
    Krácmar J; Krácmarová J; Sládková J
    Pharmazie; 1966 Aug; 21(8):460-3. PubMed ID: 5992576
    [No Abstract]   [Full Text] [Related]  

  • 39. Irreversible enzyme inhibitors. 180. Irreversible inhibitors of the C'la component of complement derived from m-(phenoxypropoxy)benzamidine and phenoxyacetamide.
    Baker BR; Cory M
    J Med Chem; 1971 Feb; 14(2):119-25. PubMed ID: 5544395
    [No Abstract]   [Full Text] [Related]  

  • 40. N-alkyl-5H-pyrido[4,3-b]indol-1-amines and derivatives as novel urotensin-II receptor antagonists.
    Wang Y; Wu Z; Guida BF; Lawrence SK; Neeb MJ; Rivero RA; Douglas SA; Jin J
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4936-9. PubMed ID: 18768319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.